We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Viper Energy
VNOM
$8.4B
| $2.36M | 0.01% |
+203,348
| New | +$1.98M |
|
877
Angi Inc
ANGI
$240M
| $2.36M | 0.01% |
17,863
-414
| -2% | -$48K |
|
|
YAC.WS
878
CALL
DELISTED
Yucaipa Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A
YAC.WS
| $2.36M | 0.01% |
+233,328
| New | +$267K |
|
879
Protagonist Therapeutics
PTGX
$8.72B
| $2.35M | 0.01% |
+116,794
| New | +$2.51M |
|
|
XOSWW
880
CALL
Xos Inc Warrants
XOSWW
$15.4K
| $2.35M | 0.01% |
+233,331
| New | +$357K |
|
|
PAE
881
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $2.34M | 0.01% |
255,199
+8,271
| +3% | +$76.4K |
|
|
VRTV
882
DELISTED
VERITIV CORPORATION
VRTV
| $2.34M | 0.01% |
112,439
+54,591
| +94% | +$981K |
|
|
FTCH
883
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $2.34M | 0.01% |
+36,612
| New | +$1.62M |
|
884
Frontline
FRO
$8.59B
| $2.31M | 0.01% |
364,713
+105,575
| +41% | +$678K |
|
885
Inseego
INSG
$114M
| $2.3M | 0.01% |
+14,858
| New | +$1.64M |
|
886
Fox Class A
FOXA
$23.8B
| $2.3M | 0.01% |
78,870
-259,120
| -77% | -$7.24M |
|
|
VER
887
DELISTED
VEREIT, Inc.
VER
| $2.29M | 0.01% |
+60,466
| New | +$2.15M |
|
888
Cboe Global Markets
CBOE
$30.2B
| $2.28M | 0.01% |
+24,527
| New | +$2.15M |
|
|
SC
889
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2.28M | 0.01% |
+103,569
| New | +$2.24M |
|
890
Aptiv
APTV
$12.2B
| $2.28M | 0.01% |
17,475
-77,643
| -82% | -$8.63M |
|
891
Turning Point Brands
TPB
$1.52B
| $2.27M | 0.01% |
51,022
-40,718
| -44% | -$1.54M |
|
892
Algonquin Power & Utilities
AQN
$4.63B
| $2.27M | 0.01% |
138,244
+103,544
| +298% | +$1.63M |
|
|
IMPX.WS
893
CALL
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
| $2.27M | 0.01% |
+224,997
| New | +$278K |
|
894
Descartes Systems
DSGX
$6.09B
| $2.27M | 0.01% |
38,843
+31,254
| +412% | +$1.77M |
|
895
Artivion
AORT
$1.27B
| $2.26M | 0.01% |
95,837
-60,144
| -39% | -$1.22M |
|
|
LITB
896
LightInTheBox
LITB
$56M
| $2.26M | 0.01% |
148,472
+50,982
| +52% | +$770K |
|
897
Heartland Express
HTLD
$1.06B
| $2.26M | 0.01% |
124,980
-136,305
| -52% | -$2.57M |
|
898
Fresenius Medical Care
FMS
$13.4B
| $2.26M | 0.01% |
54,400
-23,717
| -30% | -$988K |
|
899
Snap-on
SNA
$21.1B
| $2.26M | 0.01% |
13,208
-5,207
| -28% | -$870K |
|
900
Upbound Group
UPBD
$1.2B
| $2.25M | 0.01% |
58,892
-152,113
| -72% | -$5.17M |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.